Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway

8 Jun 2022

Abstract excerpt

It is imperative to advance the understanding of lung cancer biology. The Cancer Genome Atlas (TCGA) dataset was used for bioinformatics analysis. CCK-8 assay, flow cytometry, and western blot were performed in vitro, followed by in vivo study. We found that lncRNA Highly Accelerated Region 1A (HAR1A) is significantly downregulated in lung adenocarcinoma (LUAD) and negatively associated with prognosis. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Cytokine Signaling Pathways and Interactions
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35740511
DOI: 10.3390/cancers14122845

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 PathwayPMID 35740511Read ↗

An Efficient Five-lncRNA Signature for Lung Adenocarcinoma Prognosis and Its Overall Survival PredictionSemantic proximity Read ↗

Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Comprehensive profiling of genomic and transcriptomic differences between risk groups of lung adenocarcinoma and lung squamous cell carcinomaSemantic proximity Read ↗

The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival ratesSemantic proximity Read ↗

Genetic and tumor microenvironment differences between cell cycle progression pathway altered/non-altered patients with lung adenocarcinomaSemantic proximity Read ↗

Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung AdenocarcinomaSemantic proximity Read ↗

Molecular characterization of lung adenocarcinoma: A potential four–long noncoding RNA prognostic signatureSemantic proximity Read ↗

Study on the mechanism of lncRNAs in lung adenocarcinoma based on BioinformaticsSemantic proximity Read ↗

Deciphering N6‐Methyladenosine‐Related Genes Signature to Predict Survival in Lung AdenocarcinomaSemantic proximity Read ↗

Establishment and validation of lung adenocarcinoma aging-related genes prognostic model based on TCGA databaseSemantic proximity Read ↗

Long non-coding RNA MALAT1 in hematological malignancies and its clinical applicationsSemantic proximity Read ↗

The establishment of a prognostic model based on bioinformatic analysis of DNA damage repair genes in lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.